Zobrazeno 1 - 10
of 890
pro vyhledávání: '"W K, Cavenee"'
Autor:
Vivienne Watson
Publikováno v:
Genetical Research. 68:265-266
Autor:
Peng, Ting1,2 (AUTHOR), Zhang, Haiqiang3 (AUTHOR), Li, Lingguo4 (AUTHOR), Cao, Canhui2,5 (AUTHOR), Xu, Miaochun1,2 (AUTHOR), Liu, Xiaojie1,2 (AUTHOR), Lin, Shitong1,2 (AUTHOR), Wu, Ping2,5 (AUTHOR), Chu, Tian2,5 (AUTHOR), Liu, Binghan1,2 (AUTHOR), Xu, Yashi1,2 (AUTHOR), Zhang, Yan3 (AUTHOR), Wang, Yeqin3 (AUTHOR), Yu, Jinjin6 (AUTHOR) 9812015208@jiangnan.edu.cn, Ding, Wencheng2,5 (AUTHOR) 2014tj0072@hust.edu.cn, Jin, Xin3 (AUTHOR) jinxin@genomics.cn, Wu, Peng1,2 (AUTHOR) pengwu8626@tjh.tjmu.edu.cn
Publikováno v:
Advanced Science. 11/20/2024, Vol. 11 Issue 43, p1-14. 14p.
Autor:
S. Cheng, H. Feng, G. Y. Lopez, C. K. Kim, C. G. Duncan, A. Alvarez, R. Nishikawa, M. Nagane, A.-J. Su, P. E. Auron, M. L. Hedberg, L. Wang, J. R. Grandis, R. E. McLendon, D. D. Bigner, I. Nakano, K. Joshi, S. Kim, H.-K. Lin, F. B. Furnari, W. K. Cavenee, B. Hu, H. Yan, S.-Y. Cheng
BACKGROUND: Oncogenic EGFR-Akt signaling is aberrantly activated in human glioblastomas. Discoid, CUC and LCCL domain containing protein 2 (DCBLD2, also known as CLCP1 and ESDN) is a neuropilin-like membrane protein that is up-regulated in vascular i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b90fbb1477c636bbb6c87bea1edbf05
https://europepmc.org/articles/PMC4144529/
https://europepmc.org/articles/PMC4144529/
Autor:
Ruan, Weimin1 (AUTHOR), Xu, Sen1 (AUTHOR), An, Yang2 (AUTHOR), Cui, Yingxue1 (AUTHOR), Liu, Yang1 (AUTHOR), Wang, Yibin1 (AUTHOR), Ismail, Muhammad1 (AUTHOR), Liu, Yong3 (AUTHOR) yongliu@wmu.edu.cn, Zheng, Meng1 (AUTHOR) mzheng@henu.edu.cn
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-15. 15p.
Autor:
Bale, Ashwin A.1 (AUTHOR), Thammineni, Swaroop2 (AUTHOR), Bhargava, Rohit1,2,3,4,5 (AUTHOR) rxb@illinois.edu, Harley, Brendan1,3,5 (AUTHOR) bharley@illinois.edu
Publikováno v:
Advanced Nanobiomed Research. Sep2024, p1. 13p. 9 Illustrations.
Autor:
Xu, Chenxin1 (AUTHOR), Chen, Guoyu1 (AUTHOR), Yu, Bo1 (AUTHOR), Sun, Bowen1 (AUTHOR), Zhang, Yingwen1 (AUTHOR), Zhang, Mingda1 (AUTHOR), Yang, Yi2 (AUTHOR), Xiao, Yichuan3 (AUTHOR), Cheng, Shi‐Yuan4 (AUTHOR) shiyuan.cheng@northwestern.edu, Li, Yanxin2 (AUTHOR) liyanxin@scmc.com.cn, Feng, Haizhong1 (AUTHOR) fenghaizhong@sjtu.edu.cn
Publikováno v:
Advanced Science. 8/7/2024, Vol. 11 Issue 29, p1-21. 21p.
Publikováno v:
Cancer research. 51(6)
We have applied restriction fragment length polymorphism analysis to a 30-member panel of primary glioma DNAs, which had been previously examined for loss of genetic information (C. D. James, E. Carlbom, J. P. Dumanski, M. Hansen, M. Nordenskjold, V.
Autor:
P, Guo, L, Xu, S, Pan, R A, Brekken, S T, Yang, G B, Whitaker, M, Nagane, P E, Thorpe, J S, Rosenbaum, H J, Su Huang, W K, Cavenee, S Y, Cheng
Publikováno v:
Cancer research. 61(23)
The gene for the major angiogenic factor, vascular endothelial growth factor (VEGF), encodes several spliced isoforms. We reported previously that overexpression of two VEGF isoforms, VEGF(121) and VEGF(165), by human glioma U87 MG cells induced tumo
Publikováno v:
Apoptosis : an international journal on programmed cell death. 6(3)
Innate and acquired resistance to chemotherapy and radiation therapy has been a major obstacle for clinical oncology. One potential adjunct to such conventional treatments is direct induction of cell death by activation of death receptor-mediated apo
Publikováno v:
Journal of neuro-oncology. 46(1)
The PCAF gene encodes the p300/CBP-Associated Factor (PCAF), a histone acetyltransferase, which regulates p53 by acetylation of Lys320 in the C-terminal portion of p53. While the p53 gene is one of the most frequently mutated tumor suppressor genes i